Kerry Associates Inc. is pleased to announce that Amelot Alternative Energy, Inc. (Pink Sheets: AMHD) has signed a lease agreement for their first Bio-Diesel production facility which will have the capacity to produce ten million gallons per year. "This is a day Amelot and it shareholders can be proud of. It has been a long due-diligence period to find the right location that fits Amelot's business model. The company has made tremendous progress these first three quarters of 2006," stated Aziz Hirji, President of Amelot Holdings. The facility is an 80,000 sq. ft. building located in Nashua, New Hampshire. Amelot will lease 26,713 sq. ft. of manufacturing space and 2,969 sq. ft. of office space. "We anticipate starting our Bio-Diesel production in our first of fifty planned facilities in the next 30 to 60 days," Mr. Hirji concluded. Amelot Holdings, Inc. is a diversified holding company focused on Alternative Energy and Bio-Fuels. They have entered into the Bio-Fuels market through its subsidiary, Amelot Alternative Energy, Inc., Amelot's strategy has been to enter the market place through Bio-Diesel and Ethanol facilities. The Company's business model focuses on the launch of Bio-Diesel facilities first, and then follow with the Ethanol projects. Amelot has passed its ASTM D6751 quality assurance test results through the use of superior feed supply and technology. About Kerry Associates, Inc. Kerry Associates Inc. is a business consulting firm helping companies develop and expand into emerging markets while strategically executing their objectives. http://www.kerryassociates.com About Amelot Holdings, Inc. Amelot Holdings, Inc. is a diversified holding company focused on Alternative Energy and Bio-Fuels. http://www.amelotholdings.com Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
HLK Biotech (CE) (USOTC:AMHD)
過去 株価チャート
から 11 2024 まで 12 2024 HLK Biotech (CE)のチャートをもっと見るにはこちらをクリック
HLK Biotech (CE) (USOTC:AMHD)
過去 株価チャート
から 12 2023 まで 12 2024 HLK Biotech (CE)のチャートをもっと見るにはこちらをクリック